Showing results (41-50 of 434) with videos related to

Sort By:
Pageof 44
EJNMMI Radiopharmacy and Chemistry|March 4, 2024
Preclinical characterisation of gallium-68 labeled ferrichrome siderophore stereoisomers for PET imaging applicationsKristyna Krasulova, Barbora Neuzilova, Katerina Dvorakova Bendova, et al.
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Fully-automated radiosynthesis of the amyloid tracer [11C] PiB via direct [11C]CO2 fixation-reductionPablo Buccino, Eduardo Savio, Williams Porcal
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Radionuclide generator-based production of therapeutic 177Lu from its long-lived isomer 177mLuRupali Bhardwaj, Hubert Th Wolterbeek, Antonia G Denkova, et al.
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracersMatteo Bauckneht, Selene Capitanio, Stefano Raffa, et al.
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Have you looked for "stranger things" in your automated PET dose dispensing system? A process and operators qualification schemeTristan Martin, Anaïs Moyon, Cyril Fersing, et al.
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Radiosynthesis and in vivo evaluation of 11C-labeled BMS-193885 and its desmethyl analog as PET tracers for neuropeptide Y1 receptorsKazunori Kawamura, Wakana Mori, Masayuki Fujinaga, et al.
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Automated preparation of clinical grade [68Ga]Ga-DOTA-CP04, a cholecystokinin-2 receptor agonist, using iPHASE MultiSyn synthesis platformMohammad B Haskali, Peter D Roselt, David Binns, et al.
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Auger electrons for cancer therapy - a reviewAnthony Ku, Valerie J Facca, Zhongli Cai, et al.
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Production and characterization of no-carrier-added 161Tb as an alternative to the clinically-applied 177Lu for radionuclide therapyNadezda Gracheva, Cristina Müller, Zeynep Talip, et al.
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Evaluation of polydentate picolinic acid chelating ligands and an α-melanocyte-stimulating hormone derivative for targeted alpha therapy using ISOL-produced 225AcCaterina F Ramogida, Andrew K H Robertson, Una Jermilova, et al.
Pageof 44